TN2011000327A1 - Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals - Google Patents
Fullerene and its use to maintain good health and to prolong the expected lifespan of mammalsInfo
- Publication number
- TN2011000327A1 TN2011000327A1 TN2011000327A TN2011000327A TN2011000327A1 TN 2011000327 A1 TN2011000327 A1 TN 2011000327A1 TN 2011000327 A TN2011000327 A TN 2011000327A TN 2011000327 A TN2011000327 A TN 2011000327A TN 2011000327 A1 TN2011000327 A1 TN 2011000327A1
- Authority
- TN
- Tunisia
- Prior art keywords
- fullerene
- prolong
- mammals
- expected lifespan
- maintain good
- Prior art date
Links
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 title abstract 6
- 241000124008 Mammalia Species 0.000 title abstract 3
- 229910003472 fullerene Inorganic materials 0.000 title 1
- 230000036449 good health Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/788—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0053—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TN2011000327A TN2011000327A1 (en) | 2011-06-30 | 2011-06-30 | Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals |
| CN201810244329.0A CN108542914A (zh) | 2011-06-30 | 2012-06-28 | 富勒烯及其保持哺乳动物身体健康和延长哺乳动物预期寿命的用途 |
| CN201280037654.0A CN103826472A (zh) | 2011-06-30 | 2012-06-28 | 富勒烯及其保持哺乳动物身体健康和延长哺乳动物预期寿命的用途 |
| US14/130,020 US20140140985A1 (en) | 2011-06-30 | 2012-06-28 | Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals |
| EP12780896.2A EP2725926A1 (fr) | 2011-06-30 | 2012-06-28 | [60]fullerène et son utilisation pour maintenir des mammifères en bonne santé et prolonger leur durée de vie espérée |
| PCT/TN2012/000003 WO2013025180A1 (fr) | 2011-06-30 | 2012-06-28 | [60]fullerène et son utilisation pour maintenir des mammifères en bonne santé et prolonger leur durée de vie espérée |
| US15/927,703 US11471484B2 (en) | 2011-06-30 | 2018-03-21 | Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals |
| US18/047,181 US20230060379A1 (en) | 2011-06-30 | 2022-10-17 | Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TN2011000327A TN2011000327A1 (en) | 2011-06-30 | 2011-06-30 | Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2011000327A1 true TN2011000327A1 (en) | 2012-12-17 |
Family
ID=54696184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TN2011000327A TN2011000327A1 (en) | 2011-06-30 | 2011-06-30 | Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20140140985A1 (fr) |
| EP (1) | EP2725926A1 (fr) |
| CN (2) | CN108542914A (fr) |
| TN (1) | TN2011000327A1 (fr) |
| WO (1) | WO2013025180A1 (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TN2011000327A1 (en) | 2011-06-30 | 2012-12-17 | Fathi Moussa | Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals |
| CN104997646A (zh) * | 2015-07-09 | 2015-10-28 | 北京福纳康生物技术有限公司 | 一种富勒烯油溶性溶液及其制备方法 |
| WO2017125080A1 (fr) * | 2016-01-21 | 2017-07-27 | 北京福纳康生物技术有限公司 | Application de fullerène/métal-fullerène dans la préparation d'un produit pharmaceutique |
| CN106109494A (zh) * | 2016-08-11 | 2016-11-16 | 中国科学院化学研究所 | 预防和/或治疗骨髓抑制的微纳材料及其应用 |
| CN105596368B (zh) * | 2016-02-01 | 2019-04-16 | 北京福纳康生物技术有限公司 | 一种富勒烯橄榄油组合物及其在治疗帕金森病中的应用 |
| US10342797B2 (en) * | 2016-03-13 | 2019-07-09 | LivePet, LLC | Solubility of therapeutic agents |
| CN107753513A (zh) * | 2016-08-15 | 2018-03-06 | 北京福纳康生物技术有限公司 | 富勒烯在制备药物中的用途以及保护肝脏的药物 |
| CN106509161A (zh) * | 2016-10-24 | 2017-03-22 | 厦门福慈生物科技有限公司 | 一种抗氧化食用油及其制备方法 |
| CN106680230B (zh) * | 2017-01-06 | 2019-10-22 | 北京福纳康生物技术有限公司 | 一种富勒烯油中c60或c70的含量测定方法 |
| CN109481463B (zh) * | 2017-09-12 | 2021-04-06 | 北京福纳康生物技术有限公司 | 一种口服富勒烯乳剂、制备方法及应用 |
| CN109481464B (zh) * | 2017-09-12 | 2021-04-09 | 北京福纳康生物技术有限公司 | 一种注射用富勒烯乳剂及其制备方法 |
| CA3079723A1 (fr) * | 2017-10-16 | 2019-04-25 | Joshua Raderman | Formulations de cannabinoides et procedes comprenant l'antioxydant c60 |
| RU2679257C1 (ru) * | 2018-01-17 | 2019-02-06 | Общество с ограниченной ответственностью "С60Био" | Способ получения высококонцентрированного водного раствора фуллерена |
| CN108497099A (zh) * | 2018-03-27 | 2018-09-07 | 厦门福慈生物科技有限公司 | 富勒烯被用于制备成富勒烯微囊粉的用途 |
| WO2019184419A1 (fr) * | 2018-03-27 | 2019-10-03 | 厦门福慈生物科技有限公司 | Utilisation d'un composé de fullerène, poudre de microcapsule de fullerène et son procédé de préparation et application associée |
| US11344528B2 (en) * | 2021-01-13 | 2022-05-31 | Louis Dischler | Compositions for promoting the endogenous self-renewal of stem cells |
| US11090320B2 (en) | 2018-08-18 | 2021-08-17 | Louis Dischler | Compositions for reducing mitochondrial dysfunction |
| US11317646B2 (en) | 2018-08-18 | 2022-05-03 | Louis Dischler | Methods and compositions for rapidly decreasing epigenetic age and restoration of more youthful function |
| US11541022B2 (en) | 2018-08-18 | 2023-01-03 | Louis Dischler | Methods and compositions for the treatment of neurological diseases and syndromes of aging |
| US20200188339A1 (en) | 2018-12-14 | 2020-06-18 | Max Champie | Nutraceutical Composition Comprising C60 And Ketone Esters |
| US11179350B2 (en) | 2018-12-14 | 2021-11-23 | Max Champie | Nutraceutical compositions comprising C60 and Cox-2 inhibitor |
| US20210145762A1 (en) * | 2019-11-15 | 2021-05-20 | Redox Balance Llc | Methods of treating oxidative stress to modulate redox balance, preventing oxidative stress induced cell damage and death |
| US11504351B2 (en) | 2021-02-16 | 2022-11-22 | Louis Dischler | Methods for restoring stem cell pools and reducing epigenetic age |
| US12274713B2 (en) | 2021-05-07 | 2025-04-15 | Max C. Champie | Nutraceutical composition comprising a water-soluble fullerene and a ketone |
| US20230287577A1 (en) * | 2022-03-12 | 2023-09-14 | Razor Keep, LLC | Blade Preserving Products and Methods for Manufacturing |
| WO2024229379A1 (fr) * | 2023-05-03 | 2024-11-07 | Best Planet Science Llc | Formulations aqueuses comprenant du fullerène, de l'eau structurée, de l'hydrogène gazeux dissous, des minéraux et des additifs |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5648523A (en) | 1995-10-26 | 1997-07-15 | Chiang Long Y | Fullerene derivatives as free-radical scavengers |
| TWI250874B (en) * | 2000-03-24 | 2006-03-11 | Nat Health Research Institutes | Pharmaceutical compositions for preventing or treating disorders associated with bacterial or viral infection |
| JP4293735B2 (ja) | 2001-01-19 | 2009-07-08 | 三栄源エフ・エフ・アイ株式会社 | フラーレン誘導体およびそれからなる組成物 |
| US20030162837A1 (en) * | 2002-02-23 | 2003-08-28 | Dugan Laura L. | Carboxyfullerenes and methods of use thereof |
| WO2005105214A1 (fr) * | 2004-05-04 | 2005-11-10 | Universite Paris Sud | Compositions comportant des fullerenes hydrosolubles et leur utilisation pour la prevention de degats causes par des radicaux libres |
| JP2006160664A (ja) | 2004-12-07 | 2006-06-22 | Vitamin C60 Bioresearch Kk | フリーラジカル疾患予防治療用組成物 |
| WO2009114089A2 (fr) | 2008-03-03 | 2009-09-17 | Luna Innovations Incorporated | Utilisation de fullerenes pour augmenter et stimuler la croissance capillaire |
| TN2009000493A1 (en) | 2009-11-25 | 2011-03-31 | Fathi Moussa | Oily solutions of c [60] fullerene and their use for preventing damages caused to meatazoans by free radicals |
| US20120171121A1 (en) | 2011-01-04 | 2012-07-05 | Brown University | Rosette Nanotubes as Drug Delivery Agents |
| TN2011000327A1 (en) | 2011-06-30 | 2012-12-17 | Fathi Moussa | Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals |
| UA102139C2 (ru) | 2011-08-16 | 2013-06-10 | Киевский Национальный Университет Имени Тараса Шевченко | Способ лечения злокачественных опухолей комбинацией немодифицированных фуллеренов с60 и доксорубицина |
| CN103705388A (zh) | 2013-12-19 | 2014-04-09 | 深圳市通产丽星股份有限公司 | 一种富勒烯胶囊及其应用 |
| EP3116392A4 (fr) | 2014-03-14 | 2018-02-14 | Rhode Island Hospital | Nanovecteurs et leur traitement pour le diagnostic et la thérapeutique |
-
2011
- 2011-06-30 TN TN2011000327A patent/TN2011000327A1/fr unknown
-
2012
- 2012-06-28 WO PCT/TN2012/000003 patent/WO2013025180A1/fr not_active Ceased
- 2012-06-28 CN CN201810244329.0A patent/CN108542914A/zh active Pending
- 2012-06-28 US US14/130,020 patent/US20140140985A1/en not_active Abandoned
- 2012-06-28 CN CN201280037654.0A patent/CN103826472A/zh active Pending
- 2012-06-28 EP EP12780896.2A patent/EP2725926A1/fr not_active Ceased
-
2018
- 2018-03-21 US US15/927,703 patent/US11471484B2/en active Active
-
2022
- 2022-10-17 US US18/047,181 patent/US20230060379A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US11471484B2 (en) | 2022-10-18 |
| EP2725926A1 (fr) | 2014-05-07 |
| WO2013025180A1 (fr) | 2013-02-21 |
| US20230060379A1 (en) | 2023-03-02 |
| US20180271906A1 (en) | 2018-09-27 |
| US20140140985A1 (en) | 2014-05-22 |
| CN103826472A (zh) | 2014-05-28 |
| CN108542914A (zh) | 2018-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2011000327A1 (en) | Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals | |
| MX384514B (es) | Derivados citotoxicos de la benzodiazepina. | |
| MX2013004491A (es) | Boronatos como inhibidores de arginasa. | |
| AR081681A1 (es) | METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA | |
| MY163275A (en) | Ibat inhibitors for the treatment of liver diseases | |
| HK1211208A1 (zh) | 細胞毒性苯並二氮呯衍生物 | |
| PH12013502284A1 (en) | Protein-active agent conjugates and method for preparing the same | |
| MY164731A (en) | Compound | |
| GEP20146053B (en) | Compounds expanding hematopoietic stem cells | |
| MY184978A (en) | Pyridin-2-amides useful as cb2 agonists | |
| UA111065C2 (uk) | Композиції норибогаїну | |
| PH12014500126A1 (en) | 4-piperidinyl compounds for use as tankyrase inhibitors | |
| SG10201901824UA (en) | Cytotoxic benzodiazepine derivatives | |
| PH12013501688A1 (en) | Treatment of amyotrophic lateral sclerosis using umbilical derived cells | |
| MX2019012939A (es) | Formulaciones que contienen linaclotida para administracion oral. | |
| NZ607149A (en) | Galacto-oligosaccharide-containing composition and a method of producing it | |
| MX2011013032A (es) | Inhibidores de fosfatidilinositol 3-cinasa. | |
| NZ708821A (en) | Lfa-1 inhibitor formulations | |
| MX2011011229A (es) | Metodo para reducir la presion intraocular en los seres humanos. | |
| PH12012501098A1 (en) | 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof | |
| MY163476A (en) | Oral care compositions | |
| MX2011008645A (es) | Inhibidores de tetrahidrotiazolopiridina de fosfatidilinositol 3 cinasa. | |
| MX347541B (es) | Analogos de acido sialico. | |
| EA201391586A1 (ru) | ИНГИБИТОРЫ 17α-ГИДРОКСИЛАЗЫ/C-ЛИАЗЫ | |
| UA103197C2 (uk) | Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами |